{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:09:32Z","timestamp":1791360572370,"version":"4.3.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["#E-26\/110.420\/2014"],"award-info":[{"award-number":["#E-26\/110.420\/2014"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/010.002849\/2014"],"award-info":[{"award-number":["E-26\/010.002849\/2014"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/110743\/2012"],"award-info":[{"award-number":["E-26\/110743\/2012"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00210-022-02233-3","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T09:02:53Z","timestamp":1649235773000},"page":"789-801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cilostazol attenuates cardiac oxidative stress and inflammation in hypercholesterolemic rats"],"prefix":"10.1007","volume":"395","author":[{"given":"Rosane","family":"de Oliveira Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Ferreira","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz Ara\u00fajo","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis Jappour","family":"Autran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas Cunha","family":"de Assis Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephani Correia","family":"Braz\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Alexandre-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliete Dalla Corte","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne Br\u00eatas Vieira","family":"Scaramello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-8576","authenticated-orcid":false,"given":"Fernanda Carla Ferreira","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Alice Vieira","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"2233_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.etp.2016.01.002","volume":"68","author":"AA Abdelsameea","year":"2016","unstructured":"Abdelsameea AA, Mohamed AM, Amer MG, Attia SM (2016) Cilostazol attenuates gentamicin-induced nephrotoxicity in rats. Exp Toxicol Pathol 68:247\u2013253. https:\/\/doi.org\/10.1016\/j.etp.2016.01.002","journal-title":"Exp Toxicol Pathol"},{"key":"2233_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/FBP.0000000000000335","volume":"29","author":"SA Abuelezz","year":"2018","unstructured":"Abuelezz SA, Hendawy N (2018) Insights into the potential antidepressant mechanisms of cilostazol in chronically restraint rats: impact on the Nrf2 pathway. Behav Pharmacol 29:28\u201340. https:\/\/doi.org\/10.1097\/FBP.0000000000000335","journal-title":"Behav Pharmacol"},{"key":"2233_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.phrs.2007.04.007","volume":"56","author":"NK Agrawal","year":"2007","unstructured":"Agrawal NK, Maiti R, Dash D, Pandey BL (2007) Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients. Pharmacol Res 56:118\u2013123. https:\/\/doi.org\/10.1016\/j.phrs.2007.04.007","journal-title":"Pharmacol Res"},{"key":"2233_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.22037\/ijpr.2014.1546","volume":"13","author":"A Ahangarpour","year":"2014","unstructured":"Ahangarpour A, Heidari H, Mard SA, Hashemitabar M, Khodadadi A (2014) Progesterone and cilostazol protect mice pancreatic islets from oxidative stress induced by hydrogen peroxide. Iran J Pharm Res 13:937\u2013944. https:\/\/doi.org\/10.22037\/ijpr.2014.1546","journal-title":"Iran J Pharm Res"},{"key":"2233_CR5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.7150\/ijms.46108","volume":"17","author":"AMS Alsaad","year":"2020","unstructured":"Alsaad AMS, Mohany M, Almalki MS, Almutham I, Alahmari AA, Alsulaiman M, Al-Rejaie SS (2020) Baicalein neutralizes hypercholesterolemia-induced aggravation of oxidative injury in rats. Int J Med Sci 17:1156\u20131166. https:\/\/doi.org\/10.7150\/ijms.46108","journal-title":"Int J Med Sci"},{"key":"2233_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.5551\/jat.3392","volume":"17","author":"O Aoki","year":"2010","unstructured":"Aoki O, Hattori Y, Tomizawa A, Jojima T, Kasai K (2010) Anti-inflammatory role of cilostazol in vascular smooth muscle cells in vitro and in vivo. J Atheroscler Thromb 17:503\u2013509. https:\/\/doi.org\/10.5551\/jat.3392","journal-title":"J Atheroscler Thromb"},{"key":"2233_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1089\/ars.2005.7.889","volume":"7","author":"A Banning","year":"2005","unstructured":"Banning A, Brigelius-Floh\u00e9 R (2005) NF-\u03baB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression, Antioxidants Redox. Signal. 7:889\u2013899. https:\/\/doi.org\/10.1089\/ars.2005.7.889","journal-title":"Signal."},{"key":"2233_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.acvd.2016.02.004","volume":"109","author":"P Bobin","year":"2016","unstructured":"Bobin P, Belacel-Ouari M, Bedioune I, Zhang L, Leroy J, Leblais V, Fischmeister R, Vandecasteele G (2016) Cyclic nucleotide phosphodiesterases in heart and vessels: a therapeutic perspective. Arch Cardiovasc Dis 109:431\u2013443. https:\/\/doi.org\/10.1016\/j.acvd.2016.02.004","journal-title":"Arch Cardiovasc Dis"},{"key":"2233_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999","volume":"72","author":"M Bradford","year":"1976","unstructured":"Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1006\/abio.1976.9999","journal-title":"Anal Biochem"},{"key":"2233_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3969\/j.issn.1671-5411.2014.02.014","volume":"11","author":"SC Chattipakorn","year":"2014","unstructured":"Chattipakorn SC, Thummasorn S, Sanit J, Chattipakorn N (2014) Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart. J Geriatr Cardiol 11:151\u2013157. https:\/\/doi.org\/10.3969\/j.issn.1671-5411.2014.02.014","journal-title":"J Geriatr Cardiol"},{"key":"2233_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","volume":"50","author":"QM Chen","year":"2018","unstructured":"Chen QM, Maltagliati AJ (2018) Nrf2 at the heart of oxidative stress and cardiac protection. Physiol Genomics 50:77\u201397. https:\/\/doi.org\/10.1152\/physiolgenomics.00041.2017","journal-title":"Physiol Genomics"},{"key":"2233_CR12","doi-asserted-by":"publisher","unstructured":"Chen XL, Dodd G, Thomas S, Zhang X, Wasserman MA, Rovin BH, Kunsch C (2006) Activation of Nrf2\/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 290. https:\/\/doi.org\/10.1152\/ajpheart.00651.2005","DOI":"10.1152\/ajpheart.00651.2005"},{"key":"2233_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.thromres.2013.09.007","volume":"132","author":"Y Chen","year":"2013","unstructured":"Chen Y, Zhao S, Huang B, Wang Y, Li Y, Waqar AB, Liu R, Bai L, Fan J, Liu E (2013) Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits. Thromb Res 132:565\u2013571. https:\/\/doi.org\/10.1016\/j.thromres.2013.09.007","journal-title":"Thromb Res"},{"key":"2233_CR14","doi-asserted-by":"publisher","unstructured":"Chen Y, Pandiri I, Joe Y, Kim HJ, Kim SK, Park J, Ryu J, Cho GJ, Park JW, Ryter SW, Chung HT (2016) Synergistic effects of cilostazol and probucol on ER stress-induced hepatic steatosis via heme oxygenase-1-dependent activation of mitochondrial biogenesis. Oxidative Med Cell Longev 2016. https:\/\/doi.org\/10.1155\/2016\/3949813","DOI":"10.1155\/2016\/3949813"},{"key":"2233_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.pharep.2018.12.005","volume":"71","author":"O Cho","year":"2019","unstructured":"Cho O, Jang YJ, Park KY, Heo TH (2019) Beneficial anti-inflammatory effects of combined rosuvastatin and cilostazol in a TNF-driven inflammatory model. Pharmacol Rep 71:266\u2013271. https:\/\/doi.org\/10.1016\/j.pharep.2018.12.005","journal-title":"Pharmacol Rep"},{"key":"2233_CR16","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.pharep.2015.04.002","volume":"67","author":"Y Chtourou","year":"2015","unstructured":"Chtourou Y, Ben Slima A, Makni M, Gdoura R, Fetoui H (2015) Naringenin protects cardiac hypercholesterolemia-induced oxidative stress and subsequent necroptosis in rats. Pharmacol Rep 67:1090\u20131097. https:\/\/doi.org\/10.1016\/j.pharep.2015.04.002","journal-title":"Pharmacol Rep"},{"key":"2233_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cardiores.2007.06.006","volume":"76","author":"T Csont","year":"2007","unstructured":"Csont T, Bereczki E, Bencsik P, Fodor G, G\u00f6rbe A, Zvara \u00c1, Csonka C, Pusk\u00e1s LG, S\u00e1ntha M, Ferdinandy P (2007) Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res 76:100\u2013109. https:\/\/doi.org\/10.1016\/j.cardiores.2007.06.006","journal-title":"Cardiovasc Res"},{"key":"2233_CR18","doi-asserted-by":"publisher","first-page":"15244","DOI":"10.1074\/jbc.M113.540633","volume":"289","author":"A Cuadrado","year":"2014","unstructured":"Cuadrado A, Mart\u00edn-Moldes Z, Ye J, Lastres-Becker I (2014) Transcription factors NRF2 and NF-\u03baB are coordinated effectors of the rho family, GTP-binding protein RAC1 during Inflammation. J Biol Chem 289:15244\u201315258. https:\/\/doi.org\/10.1074\/jbc.M113.540633","journal-title":"J Biol Chem"},{"key":"2233_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/fcp.12195","volume":"30","author":"NAV da Motta","year":"2016","unstructured":"da Motta NAV, de Brito FCF (2016) Cilostazol exerts antiplatelet and anti-inflammatory effects through AMPK activation and NF-kB inhibition on hypercholesterolemic rats. Fundam Clin Pharmacol 30:327\u2013337. https:\/\/doi.org\/10.1111\/fcp.12195","journal-title":"Fundam Clin Pharmacol"},{"key":"2233_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1254\/jphs.13016FP","volume":"123","author":"NAV Da Motta","year":"2013","unstructured":"Da Motta NAV, K\u00fcmmerle AE, Marostica E, Dos Santos CF, Fraga CAM, Barreiro EJ, De Miranda ALP, De Brito FCF (2013) Anti-atherogenic effects of a new thienylacylhydrazone derivative, LASSBio-788,in rats fed a hypercholesterolemic diet. J Pharmacol Sci 123:47\u201357. https:\/\/doi.org\/10.1254\/jphs.13016FP","journal-title":"J Pharmacol Sci"},{"key":"2233_CR21","doi-asserted-by":"publisher","unstructured":"David JA, Rifkin WJ, Rabbani PS, Ceradini DJ (2017) The Nrf2\/Keap1\/ARE pathway and oxidative stress as a therapeutic target in type II diabetes mellitus. J Diabetes Res 2017. https:\/\/doi.org\/10.1155\/2017\/4826724","DOI":"10.1155\/2017\/4826724"},{"key":"2233_CR22","doi-asserted-by":"publisher","unstructured":"El-Khatib LA, De Feijter-Rupp H, Janoudi A, Fry L, Kehdi M, Abela GS (2020) Cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment. Open Hear 7. https:\/\/doi.org\/10.1136\/openhrt-2020-001274","DOI":"10.1136\/openhrt-2020-001274"},{"key":"2233_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/15376516.2018.1528648","volume":"29","author":"HM Hafez","year":"2019","unstructured":"Hafez HM, Ibrahim MA, Zedan MZ, Hassan M, Hassanein H (2019) Nephroprotective effect of cilostazol and verapamil against thioacetamide-induced toxicity in rats may involve Nrf2\/HO-1\/NQO-1 signaling pathway. Toxicol Mech Methods 29:146\u2013152. https:\/\/doi.org\/10.1080\/15376516.2018.1528648","journal-title":"Toxicol Mech Methods"},{"key":"2233_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1574884713666180903163558","volume":"14","author":"M Hassan","year":"2019","unstructured":"Hassan M, Ibrahim MA, Hafez HM, Mohamed MZ, Zenhom NM, H.M. (2019) Abd Elghany, Role of Nrf2\/HO-1 and PI3K\/Akt genes in the hepatoprotective effect of cilostazol. Curr Clin Pharmacol 14:61\u201367. https:\/\/doi.org\/10.2174\/1574884713666180903163558","journal-title":"Curr Clin Pharmacol"},{"key":"2233_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S (2016) Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 118:535\u2013546. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307611","journal-title":"Circ Res"},{"key":"2233_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/01.CIR.0000109213.10461.F6","volume":"109","author":"Y Huang","year":"2004","unstructured":"Huang Y, Walker KE, Hanley F, Narula J, Houser SR, Tulenko TN (2004) Cardiac Systolic and Diastolic Dysfunction after a Cholesterol-Rich Diet. Circulation. 109:97\u2013102. https:\/\/doi.org\/10.1161\/01.CIR.0000109213.10461.F6","journal-title":"Circulation."},{"key":"2233_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.yjmcc.2018.10.002","volume":"125","author":"M Huang","year":"2018","unstructured":"Huang M, Liu J, Sheng Y, Lv Y, Yu J, Qi H, Di W, Lv S, Zhou S, Ding G (2018) 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy. J Mol Cell Cardiol 125:106\u2013116. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.002","journal-title":"J Mol Cell Cardiol"},{"key":"2233_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajme.2017.09.001","volume":"54","author":"OM Ighodaro","year":"2018","unstructured":"Ighodaro OM, Akinloye OA (2018) First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med 54:287\u2013293. https:\/\/doi.org\/10.1016\/j.ajme.2017.09.001","journal-title":"Alexandria J Med"},{"key":"2233_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/09537100410001715583","volume":"15","author":"H Ito","year":"2004","unstructured":"Ito H, Miyakoda G, Mori T (2004) Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation. Platelets. 15:293\u2013301. https:\/\/doi.org\/10.1080\/09537100410001715583","journal-title":"Platelets."},{"key":"2233_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/ajpgi.00307.2014","volume":"309","author":"Y Joe","year":"2015","unstructured":"Joe Y, Zheng M, Kim HJ, Uddin MJ, Kim SK, Chen Y, Park J, Cho GJ, Ryter SW, Chung HT (2015) Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis. Am J Physiol Gastrointest Liver Physiol 309:21\u201329. https:\/\/doi.org\/10.1152\/ajpgi.00307.2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2233_CR31","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1476-5381.2009.00615.x","volume":"159","author":"WK Jung","year":"2010","unstructured":"Jung WK, Lee DY, Park C, Choi YH, Choi I, Park SG, Seo SK, Lee SW, Yea SS, Ahn SC, Lee CM, Park WS, Ko JH, Choi IW (2010) Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases. Br J Pharmacol 159:1274\u20131285. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00615.x","journal-title":"Br J Pharmacol"},{"key":"2233_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3803\/EnM.2015.30.4.557","volume":"30","author":"KW Kang","year":"2015","unstructured":"Kang KW, Kim OS, Chin JY, Kim WH, Park SH, Choi YJ, Shin JH, Jung KT, Lim DS, Lee SK (2015) Diastolic dysfunction induced by a high-fat diet is associated with mitochondrial abnormality and adenosine triphosphate levels in rats. Endocrinol Metab 30:557\u2013568. https:\/\/doi.org\/10.3803\/EnM.2015.30.4.557","journal-title":"Endocrinol Metab"},{"key":"2233_CR33","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00394-015-0947-5","volume":"55","author":"AI Katsarou","year":"2016","unstructured":"Katsarou AI, Kaliora AC, Chiou A, Kalogeropoulos N, Papalois A, Agrogiannis G, Andrikopoulos NK (2016) Amelioration of oxidative and inflammatory status in hearts of cholesterol-fed rats supplemented with oils or oil-products with extra virgin olive oil components. Eur J Nutr 55:1283\u20131296. https:\/\/doi.org\/10.1007\/s00394-015-0947-5","journal-title":"Eur J Nutr"},{"key":"2233_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.freeradbiomed.2015.07.016","volume":"89","author":"JS Koh","year":"2015","unstructured":"Koh JS, Yi CO, Heo RW, Ahn JW, Park JR, Lee JE, Kim JH, Hwang JY, Roh GS (2015) Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice. Free Radic Biol Med 89:54\u201361. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.07.016","journal-title":"Free Radic Biol Med"},{"key":"2233_CR35","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680\u2013685. https:\/\/doi.org\/10.1038\/227680a0","journal-title":"Nature."},{"key":"2233_CR36","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MSJ, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiograph. J Am Soc Echocardiogr 18:1440\u20131463. https:\/\/doi.org\/10.1016\/j.echo.2005.10.005","journal-title":"J Am Soc Echocardiogr"},{"key":"2233_CR37","doi-asserted-by":"publisher","unstructured":"Lee YS, Park SY, Heo HJ, Lee WS, Hong KW, Kim CD (2019) Multitarget-directed cotreatment with cilostazol and aripiprazole for augmented neuroprotection against oxidative stress-induced toxicity in HT22 mouse hippocampal cells. Eur J Pharmacol 857. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172454","DOI":"10.1016\/j.ejphar.2019.172454"},{"key":"2233_CR38","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","volume":"76","author":"W Li","year":"2008","unstructured":"Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN (2008) Activation of Nrf2-antioxidant signaling attenuates NF\u03baB-inflammatory response and elicits apoptosis. Biochem Pharmacol 76:1485\u20131489. https:\/\/doi.org\/10.1016\/j.bcp.2008.07.017","journal-title":"Biochem Pharmacol"},{"key":"2233_CR39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation. 105:1135\u20131143. https:\/\/doi.org\/10.1161\/hc0902.104353","journal-title":"Circulation."},{"key":"2233_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:1\u20139. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"2233_CR41","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1096\/fj.14-260323","volume":"29","author":"JL Marques-Rocha","year":"2015","unstructured":"Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Mart\u00ednez JA, Marti A (2015) Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J 29:3595\u20133611. https:\/\/doi.org\/10.1096\/fj.14-260323","journal-title":"FASEB J"},{"key":"2233_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.113123","volume":"212","author":"NF Nadur","year":"2021","unstructured":"Nadur NF, de Azevedo LL, Caruso L, Graebin CS, Lacerda RB, K\u00fcmmerle AE (2021) The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure. Eur J Med Chem 212:113123. https:\/\/doi.org\/10.1016\/j.ejmech.2020.113123","journal-title":"Eur J Med Chem"},{"key":"2233_CR43","doi-asserted-by":"crossref","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","DOI":"10.1016\/0003-2697(79)90738-3"},{"key":"2233_CR44","doi-asserted-by":"publisher","unstructured":"Park KY, Heo TH (2018) Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice. Cardiovasc Ther 36. https:\/\/doi.org\/10.1111\/1755-5922.12476","DOI":"10.1111\/1755-5922.12476"},{"key":"2233_CR45","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/art.27291","volume":"62","author":"SY Park","year":"2010","unstructured":"Park SY, Lee SW, Shin HK, Chung WT, Lee WS, Rhim BY, Hong KW, Kim CD (2010) Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2-linked heme oxygenase 1 induction. Arthritis Rheum 62:732\u2013741. https:\/\/doi.org\/10.1002\/art.27291","journal-title":"Arthritis Rheum"},{"key":"2233_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4196\/kjpp.2011.15.2.83","volume":"15","author":"SY Park","year":"2011","unstructured":"Park SY, Bae JU, Hong KW, Kim CD (2011) HO-1 induced by cilostazol protects against TNF-\u03b1-associated cytotoxicity via a PPAR-\u03b3-dependent pathway in human endothelial cells, Korean. J Physiol Pharmacol 15:83\u201388. https:\/\/doi.org\/10.4196\/kjpp.2011.15.2.83","journal-title":"J Physiol Pharmacol"},{"key":"2233_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1472-8206.2008.00585.x","volume":"22","author":"E Ramesh","year":"2008","unstructured":"Ramesh E, Elanchezhian R, Sakthivel M, Jayakumar T, Senthil Kumar RS, Geraldine P, Thomas PA (2008) Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundam Clin Pharmacol 22:275\u2013284. https:\/\/doi.org\/10.1111\/j.1472-8206.2008.00585.x","journal-title":"Fundam Clin Pharmacol"},{"key":"2233_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cbi.2009.02.013","volume":"180","author":"E Ramesh","year":"2009","unstructured":"Ramesh E, Jayakumar T, Elanchezhian R, Sakthivel M, Geraldine P, Thomas PA (2009) Green tea catechins, alleviate hepatic lipidemic-oxidative injury in Wistar rats fed an atherogenic diet. Chem Biol Interact 180:10\u201319. https:\/\/doi.org\/10.1016\/j.cbi.2009.02.013","journal-title":"Chem Biol Interact"},{"key":"2233_CR49","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","volume":"26","author":"DP Ramji","year":"2015","unstructured":"Ramji DP, Davies TS (2015) Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev 26:673\u2013685. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.04.003","journal-title":"Cytokine Growth Factor Rev"},{"key":"2233_CR50","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","volume":"110","author":"R Rosenhek","year":"2004","unstructured":"Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, Schemper M, Binder T, Maurer G, Baumgartner H (2004) Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 110:1291\u20131295. https:\/\/doi.org\/10.1161\/01.CIR.0000140723.15274.53","journal-title":"Circulation."},{"key":"2233_CR51","unstructured":"Sahin M, Baytaroglu C, Sevgili E (2021) Cardioprotective effect of cilostazol on ischemia-reperfusion injury model., Brazilian. J Cardiovasc Surg:10.21470\/1678-9741-2020-0651"},{"key":"2233_CR52","doi-asserted-by":"publisher","unstructured":"Sozen E, Yazgan B, Tok OE, Demirel T, Ercan F, Proto JD, Ozer NK (2020) Cholesterol induced autophagy via IRE1\/JNK pathway promotes autophagic cell death in heart tissue. Metabolism. 106. https:\/\/doi.org\/10.1016\/j.metabol.2020.154205","DOI":"10.1016\/j.metabol.2020.154205"},{"key":"2233_CR53","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.002","volume":"24","author":"L Tan","year":"2015","unstructured":"Tan L, Margaret B, Zhang JH, Hu R, Yin Y, Cao L, Feng H, Zhang Y (2015) Efficacy and safety of cilostazol therapy in ischemic stroke: a meta-analysis. J Stroke Cerebrovasc Dis 24:930\u2013938. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.12.002","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2233_CR54","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1074248418763957","volume":"23","author":"MK Tawfik","year":"2018","unstructured":"Tawfik MK, El-Kherbetawy MK, Makary S (2018) Cardioprotective and anti-aggregatory effects of levosimendan on isoproterenol-induced myocardial injury in high-fat-fed rats involves modulation of PI3K\/Akt\/mTOR signaling pathway and inhibition of apoptosis: comparison to cilostazol. J Cardiovasc Pharmacol Ther 23:456\u2013471. https:\/\/doi.org\/10.1177\/1074248418763957","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2233_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-11-74","volume":"11","author":"CE van den Brom","year":"2012","unstructured":"van den Brom CE, Bulte CSE, Kloeze BM, Loer SA, Boer C, Bouwman RA (2012) High fat diet-induced glucose intolerance impairs myocardial function, but not myocardial perfusion during hyperaemia: a pilot study. Cardiovasc Diabetol 11:1\u20137. https:\/\/doi.org\/10.1186\/1475-2840-11-74","journal-title":"Cardiovasc Diabetol"},{"key":"2233_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yjmcc.2013.05.009","volume":"62","author":"ZV Varga","year":"2013","unstructured":"Varga ZV, Kupai K, Szucs G, G\u00e1sp\u00e1r R, P\u00e1l\u00f3czi J, Farag\u00f3 N, Zvara \u00c1, Pusk\u00e1s LG, R\u00e1zga Z, Tiszlavicz L, Bencsik P, G\u00f6rbe A, Csonka C, Ferdinandy P, Csont T (2013) MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative\/nitrative stress and subsequent dysfunction in the heart. J Mol Cell Cardiol 62:111\u2013121. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.05.009","journal-title":"J Mol Cell Cardiol"},{"key":"2233_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1423-0127-19-22","volume":"19","author":"EC Vasquez","year":"2012","unstructured":"Vasquez EC, Peotta VA, Gava AL, Pereira TMC, Meyrelles SS (2012) Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. J Biomed Sci 19:1\u20139. https:\/\/doi.org\/10.1186\/1423-0127-19-22","journal-title":"J Biomed Sci"},{"key":"2233_CR58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/nu12010068","volume":"12","author":"DF Vileigas","year":"2020","unstructured":"Vileigas DF, de Marciano CLC, Mota GAF, de Souza SLB, Sant\u2019ana PG, Okoshi K, Padovani CR, Cicogna AC (2020) Temporal measures in cardiac structure and function during the development of obesity induced by different types of western diet in a rat model. Nutrients. 12:68. https:\/\/doi.org\/10.3390\/nu12010068","journal-title":"Nutrients."},{"key":"2233_CR59","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00005344-200111000-00014","volume":"38","author":"S Wang","year":"2001","unstructured":"Wang S, Cone J, Fong M, Yoshitake M, Kambayashi JI, Liu Y (2001) Interplay between inhibition of adenosine uptake and phosphodiesterase type 3 on cardiac function by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol 38:775\u2013783. https:\/\/doi.org\/10.1097\/00005344-200111000-00014","journal-title":"J Cardiovasc Pharmacol"},{"key":"2233_CR60","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.lfs.2008.09.027","volume":"83","author":"F Wang","year":"2008","unstructured":"Wang F, Li M, Cheng L, Zhang T, Hu J, Cao M, Zhao J, Guo RC, Gao L, Zhang X (2008) Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats. Life Sci 83:828\u2013835. https:\/\/doi.org\/10.1016\/j.lfs.2008.09.027","journal-title":"Life Sci"},{"key":"2233_CR61","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.14670\/HH-29.1593","volume":"29","author":"Y Wang","year":"2014","unstructured":"Wang Y, Bai L, Lin Y, Guan H, Zhu N, Chen Y, Li Y, Gao S, Zhao S, Fan J, Liu E (2014) Demonstration of an add-on effect of probucol and cilostazol on the statin-induced anti-atherogenic effects. Histol Histopathol 29:1593\u20131600. https:\/\/doi.org\/10.14670\/HH-29.1593","journal-title":"Histol Histopathol"},{"key":"2233_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-015-0083-5","volume":"14","author":"Y Wang","year":"2015","unstructured":"Wang Y, Bai L, Lin Y, Chen Y, Guan H, Zhu N, Li Y, Gao S, Sun L, Zhao S, Fan J, Liu E (2015) Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits. Lipids Health Dis 14:1\u20138. https:\/\/doi.org\/10.1186\/s12944-015-0083-5","journal-title":"Lipids Health Dis"},{"key":"2233_CR63","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem Soc Trans 43:621\u2013626. https:\/\/doi.org\/10.1042\/BST20150014","journal-title":"Biochem Soc Trans"},{"key":"2233_CR64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5551\/jat.40956","volume":"25","author":"S Watanabe","year":"2018","unstructured":"Watanabe S, Kumazaki S, Kusunoki K, Inoue T, Maeda Y, Usui S, Shinohata R, Ohtsuki T, Hirohata S, Kusachi S, Kitamori K, Mori M, Yamori Y, Oka H (2018) A high-fat and high-cholesterol diet induces cardiac fibrosis, vascular endothelial, and left ventricular diastolic dysfunction in shrsp5\/dmcr rats. J Atheroscler Thromb 25:439\u2013453. https:\/\/doi.org\/10.5551\/jat.40956","journal-title":"J Atheroscler Thromb"},{"key":"2233_CR65","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2147\/DMSO.S248948","volume":"13","author":"H Yang","year":"2020","unstructured":"Yang H, Xin X, Yu H, Bao Y, Jia P, Wu N, Jia D (2020) MicroRNA expression profiles in myocardium of high-fat diet-induced obesity rat, Diabetes. Metab Syndr Obes Targets Ther 13:1147\u20131159. https:\/\/doi.org\/10.2147\/DMSO.S248948","journal-title":"Metab Syndr Obes Targets Ther"},{"key":"2233_CR66","doi-asserted-by":"publisher","first-page":"11804","DOI":"10.3390\/ijms160511804","volume":"16","author":"SW Youn","year":"2015","unstructured":"Youn SW, Park KK (2015) Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosis. Int J Mol Sci 16:11804\u201311833. https:\/\/doi.org\/10.3390\/ijms160511804","journal-title":"Int J Mol Sci"},{"key":"2233_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.arcmed.2012.12.001","volume":"44","author":"HP Zhang","year":"2013","unstructured":"Zhang HP, Zheng FL, Zhao JH, Guo DX, Chen XL (2013) Genistein Inhibits ox-LDL-induced VCAM-1, ICAM-1 and MCP-1 Expression of HUVECs Through Heme Oxygenase-1. Arch Med Res 44:13\u201320. https:\/\/doi.org\/10.1016\/j.arcmed.2012.12.001","journal-title":"Arch Med Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02233-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T04:18:37Z","timestamp":1655093917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02233-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02233-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"6 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal care and procedures were in accordance with the conventional guidelines for experimentation with animals (National Institute of Health Guide, 8th edition, 2011). The Ethics Committee on Animal Use of the Fluminense Federal University approved all protocols and procedures used in this study (Protocol number 858\/16).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}